Valuation : Embla Medical hf.

Market Cap 1.79B 11.55B 1.54B 1.46B 1.33B 2.49B 171B 2.5B 17.37B 6.68B 87.15B 6.73B 6.59B 275B P/E 2026 *
18.1x
P/E 2027 * 15.8x
Enterprise Value 2.19B 14.12B 1.89B 1.79B 1.62B 3.04B 209B 3.06B 21.24B 8.17B 107B 8.23B 8.05B 337B EV / Sales 2026 *
2.15x
EV / Sales 2027 * 1.95x
Free-Float
36.89%
Yield 2026 *
-
Yield 2027 * -
1 day-1.99%
1 week-5.57%
Current month-7.02%
1 month-9.20%
3 months+2.07%
6 months-6.06%
Current year-16.46%
1 week 26.9
Extreme 26.9
28.7
1 month 26.9
Extreme 26.9
30.45
Current year 25
Extreme 25
33.1
1 year 25
Extreme 25
37.9
3 years 25
Extreme 25
38
5 years 25
Extreme 25
46.55
10 years 22.5
Extreme 22.5
57.8
Manager TitleAgeSince
Chief Executive Officer 48 31/03/2022
Director of Finance/CFO 60 31/08/2022
Chief Tech/Sci/R&D Officer - 23/02/2025
Director TitleAgeSince
Director/Board Member 58 31/12/2008
Chairman 69 31/12/2005
Director/Board Member 61 31/01/2008
Date Insider Type Main position Quantity % Market Cap. Importance
22/12/25 BuyCompany 10,400 0.0024%
15/12/25 BuyCompany 45,275 0.0106%
08/12/25 BuyCompany 30,000 0.0070%
Change 5-day change 1-year change 3-year change Capi.($)
-1.99%-5.57%-6.70%-9.80% 1.79B
+0.56%+0.17%+1.47%-26.48% 18.39B
-1.39%-3.66%-5.95%+4.19% 16.47B
-2.50%-6.02%-54.93%-49.87% 6.29B
+0.36%-4.29% - - 4.14B
-5.51%-12.31%+24.00%+55.11% 1.89B
-2.21%-4.53%-52.86%-61.08% 1.08B
-0.40%-5.70%+31.86%+138.78% 887M
+0.70%-3.46%+42.95%+224.69% 552M
-3.30%-5.06% - - 291M
Average -1.57%-5.14%-2.52%+34.44% 5.18B
Weighted average by Cap. -0.85%-3.10%-8.21%-9.81%

Financials

2026 *2027 *
Net sales 1.02B 6.57B 879M 832M 754M 1.41B 97.44B 1.42B 9.88B 3.8B 49.58B 3.83B 3.75B 157B 1.1B 7.09B 948M 897M 813M 1.53B 105B 1.53B 10.66B 4.1B 53.46B 4.13B 4.04B 169B
Net income 97.9M 631M 84.35M 79.87M 72.39M 136M 9.35B 137M 949M 365M 4.76B 368M 360M 15.04B 111M 714M 95.45M 90.38M 81.92M 154M 10.58B 154M 1.07B 413M 5.38B 416M 407M 17.01B
Net Debt 399M 2.57B 343M 325M 295M 553M 38.08B 556M 3.86B 1.49B 19.38B 1.5B 1.46B 61.22B 354M 2.28B 305M 289M 262M 491M 33.79B 493M 3.43B 1.32B 17.19B 1.33B 1.3B 54.32B
Logo Embla Medical hf.
Embla Medical hf, formerly Ossur hf, is an Iceland-based company that operates within the field of medical equipment and supplies sector. The Company is active in the development and distribution of products in the fields of non-invasive prosthetics, medical braces and supports. The Company's business activities are divided into three business segment: The Prosthetics, its product portfolio includes a range of lower and upper limb prosthetic components; The Bracing & Supports, which offers the Unloader One range of knee braces that relieve pain from knee osteoarthritis, as well as the Unloader Hip which is designed to reduce pain by optimizing load dispersion for patients suffering from mild and moderate osteoarthritis of the hip; and The Patient Care, which operates a network of Patient Care clinics around the world, with each one catering to individual patients and their needs.
Employees
4,500
Date Price Change Volume
11/09/26 DKK 27.15 -1.99% 79,417
10/09/26 DKK 27.70 -0.54% 90,431
09/09/26 DKK 27.85 -2.11% 43,827
08/09/26 DKK 28.45 +0.18% 35,244
07/09/26 DKK 28.40 -1.22% 52,672
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
27.15DKK
Average target price
33.50DKK
Spread / Average Target
+23.39%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. EMBLA Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!